Position in NVS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,079,295
+$79,788 QoQ
Shares Held
32,410
-1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#259
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. NVS ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
This page
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,079,295 | 32,410 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $4,999,507 | 32,730 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,478,017 | 32,480 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $3,953,639 | 30,830 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $3,775,148 | 31,197 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,583,747 | 32,147 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $3,147,686 | 32,347 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,853,400 | 33,502 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,449,516 | 32,402 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,164,231 | 32,712 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,338,270 | 33,062 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $3,357,509 | 32,962 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,313,581 | 32,837 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $3,067,004 | 33,337 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $3,010,724 | 33,187 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,610,715 | 34,347 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,932,937 | 34,697 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,114,861 | 35,497 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,276,363 | 37,457 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $3,142,968 | 38,432 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $3,528,433 | 38,672 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $3,266,361 | 38,212 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $5,242,753 | 55,520 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $4,729,319 | 54,385 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $4,664,480 | 53,406 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $4,439,850 | 53,849 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||